Daniel Barber, President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 25,000 shares at $4.22 ($106K) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Open-market sale of $106k AQST by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-05-18 | $35K | — | Filing → |